Patient Capital Management 13F, Q1 2026

Samantha McLemore · quarter ending 31 March 2026 · filed 14 May 2026 · SEC CIK 1854794

$2.68B
Filed US book
38
Positions
6.5%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 2 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.

Largest positions, Q1 2026

The 25 largest of 38 positions. Weights are against the whole filed book. Changes are in shares held, against the Q4 2025 filing.

CompanyTickerValue% of bookvs Q4 2025
ROYALTY PHARMA PLC$174.79M6.5%+9% shares
CITIGROUP INCC$160.35M6.0%+10% shares
ALPHABET INCGOOGL$153.56M5.7%-8% shares
AMAZON COM INCAMZN$136.30M5.1%+16% shares
QXO INCQXO$131.64M4.9%+5% shares
NVIDIA CORPORATIONNVDA$124.02M4.6%+11% shares
UNITEDHEALTH GROUP INCUNH$118.29M4.4%+19% shares
ENERGY TRANSFER L PET$117.50M4.4%+16% shares
IAC INCPPLI$108.06M4.0%+14% shares
NORWEGIAN CRUISE LINE HLDGS$107.52M4.0%+8% shares
SEADRILL LTD$97.95M3.6%+5% shares
META PLATFORMS INCMETA$97.88M3.6%+20% shares
CVS HEALTH CORPCVS$97.47M3.6%+10% shares
COINBASE GLOBAL INCCOIN$75.15M2.8%+141% shares
ADOBE INCADBE$72.26M2.7%new
CROCS INCCROX$69.97M2.6%+11% shares
BIOGEN INCBIIB$69.62M2.6%-34% shares
PRECIGEN INCPGEN$68.95M2.6%-5% shares
UNITED AIRLS HLDGS INCUAL$67.40M2.5%+12% shares
ILLUMINA INCILMN$67.15M2.5%-5% shares
NOBLE CORP PLC$66.14M2.5%+5% shares
GENERAL MTRS COGM$55.47M2.1%-4% shares
FISERV INCFISV$54.03M2.0%+274% shares
CHIME FINL INCCHYM$53.98M2.0%+42% shares
UBS GROUP AG$48.52M1.8%+5% shares

What changed since Q4 2025

Against the Q4 2025 filing, Patient Capital Management opened 2 new positions, added to 23, trimmed 10, left 3 unchanged and exited 4. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

Exited

Added to

  • ROYALTY PHARMA PLC+9%$174.79M
  • C+10%$160.35M
  • AMZN+16%$136.30M
  • QXO+5%$131.64M
  • NVDA+11%$124.02M
  • UNH+19%$118.29M
  • ET+16%$117.50M
  • PPLI+14%$108.06M

and 15 more

Trimmed

and 2 more

Other quarters

Source: SEC Form 13F-HR, accession 0001854794-26-000004, filed by Patient Capital Management, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.